Trial intelligence / Profile preview

Short-Course Radiotherapy + CAPOX + Enlonstobart for pMMR Locally Advanced Rectal Cancer

NCT07448077Phase 2Recruiting

Sponsor
The Fourth Hospital of Hebei Medical University
Start
Mar 2026
Primary completion
Mar 2026
Modality
Monoclonal Antibodies
Countries
1
01

Overview

A Phase 2 trial of PBI-1308 in rectal cancer, sponsored by The Fourth Hospital of Hebei Medical University. Started Mar 2026; status: recruiting.

02

Drugs

PBI-1308
03

Conditions

rectal cancer

Beyond the preview

Go deeper on NCT07448077.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07448077.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call